Esperion Therapeutics
ESPR
#6204
Rank
S$1.11 B
Marketcap
S$4.71
Share price
-1.62%
Change (1 day)
41.95%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): S-$0.66

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.65. In 2024 the company made an earnings per share (EPS) of S-$0.30 an increase over its 2023 EPS that were of S-$2.74.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.66123.44%
2024S-$0.30-89.15%
2023S-$2.74-40.28%
2022S-$4.58-62.87%
2021S-$12.3480.38%
2020S-$6.8450.14%
2019S-$4.56-53.18%
2018S-$9.737.41%
2017S-$9.06110.81%
2016S-$4.3047.35%
2015S-$2.920.89%
2014S-$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
S-$7.67 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$3.51-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.22-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$56.08-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S-$0.25-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA